Cargando…
Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
BACKGROUND: To study on expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocarcinoma (GC). METHODS: Expressions of CD133 protein by immunostaining (99 cases) and CD133 mRNA by semi-quantitative RT-PCR (31 cases) were detected in primary lesion an...
Autores principales: | Yu, Ji-wei, Zhang, Peng, Wu, Ju-gang, Wu, Sheng-hua, Li, Xiao-qiang, Wang, Shi-ting, Lu, Rui-qi, Ni, Xiao-chun, Jiang, Bo-jian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987897/ https://www.ncbi.nlm.nih.gov/pubmed/21054902 http://dx.doi.org/10.1186/1756-9966-29-141 |
Ejemplares similares
-
Preliminary Study on the Expression and the Clinical Significance of CD133 in Peripheral Blood of Patients with Gastric Adenocarcinoma
por: Wu, Ju-gang, et al.
Publicado: (2014) -
Study on the Biological Characteristics of CD133(+) Cells Interfered by RNA Interference in Gastric Cancer
por: Yu, Ji-wei, et al.
Publicado: (2014) -
Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018) -
CD133 expression in different stages of gastric adenocarcinoma
por: Boegl, M, et al.
Publicado: (2009) -
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)